全文获取类型
收费全文 | 10063篇 |
免费 | 921篇 |
国内免费 | 4篇 |
专业分类
10988篇 |
出版年
2022年 | 87篇 |
2021年 | 124篇 |
2020年 | 81篇 |
2019年 | 91篇 |
2018年 | 129篇 |
2017年 | 124篇 |
2016年 | 211篇 |
2015年 | 355篇 |
2014年 | 426篇 |
2013年 | 513篇 |
2012年 | 646篇 |
2011年 | 660篇 |
2010年 | 473篇 |
2009年 | 399篇 |
2008年 | 565篇 |
2007年 | 561篇 |
2006年 | 504篇 |
2005年 | 548篇 |
2004年 | 573篇 |
2003年 | 506篇 |
2002年 | 532篇 |
2001年 | 130篇 |
2000年 | 119篇 |
1999年 | 161篇 |
1998年 | 168篇 |
1997年 | 76篇 |
1996年 | 106篇 |
1995年 | 86篇 |
1994年 | 96篇 |
1993年 | 112篇 |
1992年 | 114篇 |
1991年 | 99篇 |
1990年 | 117篇 |
1989年 | 96篇 |
1988年 | 104篇 |
1987年 | 81篇 |
1986年 | 85篇 |
1985年 | 87篇 |
1984年 | 95篇 |
1983年 | 76篇 |
1982年 | 87篇 |
1981年 | 92篇 |
1980年 | 59篇 |
1979年 | 77篇 |
1978年 | 52篇 |
1977年 | 59篇 |
1976年 | 64篇 |
1975年 | 39篇 |
1974年 | 42篇 |
1973年 | 45篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
91.
92.
Monica J. Justice Linda D. Siracusa A. Francis Stewart 《Disease models & mechanisms》2011,4(3):305-310
The mouse is the leading organism for disease research. A rich resource of genetic variation occurs naturally in inbred and special strains owing to spontaneous mutations. However, one can also obtain desired gene mutations by using the following processes: targeted mutations that eliminate function in the whole organism or in a specific tissue; forward genetic screens using chemicals or transposons; or the introduction of exogenous transgenes as DNAs, bacterial artificial chromosomes (BACs) or reporter constructs. The mouse is the only mammal that provides such a rich resource of genetic diversity coupled with the potential for extensive genome manipulation, and is therefore a powerful application for modeling human disease. This poster review outlines the major genome manipulations available in the mouse that are used to understand human disease: natural variation, reverse genetics, forward genetics, transgenics and transposons. Each of these applications will be essential for understanding the diversity that is being discovered within the human population. 相似文献
93.
94.
95.
96.
97.
Thomas H. Beckham Joseph C. Cheng Ping Lu S. Tucker Marrison James S. Norris Xiang Liu 《PloS one》2013,8(10)
The tumor suppressor PTEN is now understood to regulate cellular processes at the cytoplasmic membrane, where it classically regulates PI3K signaling, as well as in the nucleus where multiple roles in controlling cell cycle and genome stability have been elucidated. Mechanisms that dictate nuclear import and, less extensively, nuclear export of PTEN have been described, however the relevance of these processes in disease states, particularly cancer, remain largely unknown. We investigated the impact of acid ceramidase on the nuclear-cytoplasmic trafficking of PTEN. Immunohistochemical analysis of a human prostate tissue microarray revealed that nuclear PTEN was lost in patients whose tumors had elevated acid ceramidase. We found that acid ceramidase promotes a reduction in nuclear PTEN that is dependent upon sphingosine 1-phosphate-mediated activation of Akt. We were further able to show that sphingosine 1-phosphate promotes formation of a complex between Crm1 and PTEN, and that leptomycin B prevents acid ceramidase and sphingosine 1-phosphate mediated loss of nuclear PTEN, suggesting an active exportin-mediated event. To investigate whether the tumor promoting aspects of acid ceramidase in prostate cancer depend upon its ability to export PTEN from the nucleus, we used enforced nuclear expression of PTEN to study docetaxel-induced apoptosis and cell killing, proliferation, and xenoengraftment. Interestingly, while acid ceramidase was able to protect cells expressing wild type PTEN from docetaxel, promote proliferation and xenoengraftment, acid ceramidase had no impact in cells expressing PTEN-NLS. These findings suggest that acid ceramidase, through sphingosine 1-phosphate, promotes nuclear export of PTEN as a means of promoting tumor formation, cell proliferation, and resistance to therapy. 相似文献
98.
Unusual trend in the prevalence of trisomy 13 in mothers aged 35 and older: A population based study of national congenital anomaly data 下载免费PDF全文
99.
Cairns L Cirò M Minuzzo M Morlé F Starck J Ottolenghi S Ronchi A 《Journal of cellular physiology》2003,195(1):38-49
Erythropoiesis requires the stepwise action on immature progenitors of several growth factors, including stem cell factor (SCF), interleukin 3 (IL-3), and erythropoietin (Epo). Epo is required to sustain proliferation and survival of committed progenitors and might further modulate the level of expression of several erythroid genes, including globin genes. Here we report a new SCF-dependent immortalized mouse progenitor cell line (GATA-1 ts SCF) that can also grow in either Epo or IL-3 as the sole growth factor. When grown in SCF, these cells show an "open" chromatin structure of the beta-globin LCR, but do not significantly express globin. However, Epo or IL-3 induce globin expression and are required for its maintainance. This effect of IL-3 is unexpected as IL-3 was previously reported either to be unable to induce hemoglobinization, or even to antagonize it. This suggests that GATA-1 ts SCF cells may have progressed to a stage in which globin genes are already poised for expression and only require signal(s) that can be elicited by either Epo or IL-3. Through the use of inhibitors, we suggest that p38 may be one of the molecules modulating induction and maintenance of globin expression. 相似文献
100.